8-K: Barinthus Biotherapeutics Promotes Graham Griffiths to Chief Operating Officer
Executive Change Announcement
Barinthus Biotherapeutics has promoted its Chief Business Officer, Graham Griffiths, to Chief Operating Officer, effective September 1, 2024.
Summary
- Barinthus Biotherapeutics has announced the promotion of Graham Griffiths from Chief Business Officer to Chief Operating Officer.
- The promotion was effective September 1, 2024.
- Mr. Griffiths has served as the company's Chief Business Officer since October 2017.
- Prior to joining Barinthus, Mr. Griffiths was the Chief Operating Officer, co-founder, and a board member of Agalimmune Limited from May 2013 to September 2017.
- In connection with his promotion, Mr. Griffiths' salary has been increased to 336,144.
- There are no known arrangements or understandings between Mr. Griffiths and any other persons regarding his promotion.
- There are no family relationships between Mr. Griffiths and any director or executive officer of the company.
- There are no related person transactions between Mr. Griffiths and the company.
Sentiment
Score: 7
Explanation: The document reflects a positive internal development with the promotion of an existing executive, suggesting stability and growth within the company.
Positives
- The promotion of Graham Griffiths to COO demonstrates internal talent development and recognition within Barinthus Biotherapeutics.
- Mr. Griffiths' prior experience as COO at Agalimmune Limited suggests he is well-suited for the new role.
- The salary increase indicates the company's commitment to compensating its executives fairly.
Industry Context
Executive promotions are common in the biotechnology industry as companies grow and evolve, and this move reflects Barinthus Biotherapeutics' development.
Comparison to Industry Standards
- Executive compensation in the biotechnology sector varies widely based on company size, stage of development, and location.
- A salary of 336,144 for a COO position at a company like Barinthus Biotherapeutics is within the typical range for a company of its size and stage of development.
- Comparable companies in the biotechnology sector often have similar executive compensation structures, including base salaries, bonuses, and stock options.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer | Vacant | Graham Griffiths | 2024-09-01 | Promotion from Chief Business Officer |
Stakeholder Impact
- Shareholders may view this promotion positively as it indicates internal talent development.
- Employees may see this as a positive sign of career progression opportunities within the company.
Key Dates
| Date | Description |
|---|---|
| 2013-05 | Graham Griffiths became Chief Operating Officer, co-founder and a member of the board of directors of Agalimmune Limited. |
| 2017-09 | Graham Griffiths left Agalimmune Limited. |
| 2017-10 | Graham Griffiths became Chief Business Officer of Barinthus Biotherapeutics. |
| 2024-09-01 | Effective date of Graham Griffiths' promotion to Chief Operating Officer and salary increase. |
| 2024-09-05 | Date of the 8-K filing. |
Keywords
Chief Operating Officer, executive promotion, Graham Griffiths, Barinthus Biotherapeutics, management change, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.